BRIEF published on 04/29/2026 at 12:05, 4 months 11 days ago Arkema annonce les détails de son assemblée générale annuelle pour 2026 Actionnaires Paris Réunion Annuelle ARKEMA Matériaux Spéciaux
BRIEF published on 04/29/2026 at 12:05, 4 months 11 days ago Arkema Announces Annual General Meeting Details for 2026 Shareholders Paris Annual Meeting ARKEMA Specialty Materials
PRESS RELEASE published on 04/29/2026 at 12:00, 4 months 11 days ago Informations privilégiées / Autres communiqués Arkema annonce la mise à disposition des informations relatives à l'Assemblée Générale Mixte du 21 mai 2026. Détails sur le site internet d'Arkema. Présentation des activités du Groupe Informations Réglementées Assemblée Générale Mixte ARKEMA Matériaux De Spécialités CA 2025
PRESS RELEASE published on 04/29/2026 at 12:00, 4 months 11 days ago Inside Information / Other news releases Arkema invites shareholders to the combined annual general meeting on 21 May 2026 in Paris. The company offers sustainable materials and technological solutions. Contact investor relations for more info Annual General Meeting Shareholders Investor Relations Sustainable Materials ARKEMA
BRIEF published on 04/02/2026 at 19:26, 5 months 8 days ago Arkema publie des informations mises à jour sur ses actions et ses droits de vote Actions Droit De Vote Code De Commerce Français ARKEMA Conformité AMF
BRIEF published on 04/02/2026 at 19:26, 5 months 8 days ago ARKEMA : Déclaration du Nombre Total d'Actions et de Droits de Vote Droits De Vote Actions Information Réglementée Marchés Financiers ARKEMA
BRIEF published on 04/02/2026 at 19:26, 5 months 8 days ago Arkema Discloses Updated Share and Voting Rights Information Voting Rights French Commercial Code Shares ARKEMA AMF Compliance
BRIEF published on 04/02/2026 at 19:26, 5 months 8 days ago ARKEMA: Declaration of the Total Number of Shares and Voting Rights Voting Rights Actions Regulated Information Financial Markets ARKEMA
PRESS RELEASE published on 04/02/2026 at 19:21, 5 months 8 days ago Informations privilégiées / Autres communiqués Déclaration du nombre total de droits de vote et d’actions pour le 2 avril 2026 conformément aux réglementations financières Autorité Des Marchés Financiers Déclaration Droits De Vote Actions Information Réglementée
PRESS RELEASE published on 04/02/2026 at 19:21, 5 months 8 days ago Inside Information / Other news releases Press release regarding disclosure of shares and voting rights under French commercial code and Financial Markets Authority regulations Voting Rights French Commercial Code Shares Financial Markets Authority Regulated Information
Published on 09/11/2026 at 04:00, 6 hours 12 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 47 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 52 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 12 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 51 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 6 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 11 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 12 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 3 hours 12 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 12 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 42 minutes ago Availability of the 2026 Interim Financial Report
